The forecast for ovary malignant neoplasms mortality in Brazil indicates a stable trend from 2024 to 2028, with a standardized rate of 5.2 female deaths per hundred thousand women each year. In 2023, the rate was also at a similar level, suggesting no year-on-year percentage variation. This stability implies no compound annual growth rate (CAGR) change over the past few years, indicating a steady state in mortality rates.

Future trends to watch for include:

Potential impacts of new healthcare policies or initiatives targeting early detection and treatment.
Changes in healthcare access and quality that might influence mortality rates.
Research and innovation in ovary cancer treatments that could alter future forecasts.
Socioeconomic factors influencing healthcare outcomes for women in Brazil.